Persistence of autoantibodies against recombinant mitochondrial and nuclear pore proteins after orthotopic liver transplantation for primary biliary cirrhosis.

Primary biliary cirrhosis is an autoimmune disease characterized by high titer autoantibodies predominantly against mitochondrial antigens PDC-E2, BCOADC-E2 and OGDC-E2. Currently orthotopic liver transplant (OLT) is the major form of treatment for end-stage primary biliary cirrhosis (PBC), but it is still unclear whether the autoimmune response continues post-transplantation. In this study we took advantage of a well-defined collection of sera collected serially before and after liver transplantation. We assayed these sera for quantitative and isotype-specific titers of antibodies against a set of recombinant mitochondrial autoantigens. We also studied reactivity to gp210. Serum samples were taken before transplantation and at intervals of 6 months, 1, 2, and 3 years after OLT. Before OLT 24/35 patients were AMA-positive, including seven out of the 35 to PDC-E2 alone, eight to both PDC-E2 and OGDC-E2, six to both PDC-E2 and BCOADC-E2, two to BCOADC-E2 alone and one to OGDC-E2. Following OLT, the frequency of sera that responded to PDC-E2 alone increased from seven to 12/35. Similarly, reactivity to BCOADC-E2 slightly increased from two to four out of 35. However, there was an overall decrease in sera that responded to more than one antigen. Neither Ig isotype nor subclass of the autoimmune response changed following OLT. Findings with gp210 were similar, in that reactivity to gp210 was found in nine out of 35 patients pre-OLT; following OLT the frequency decreased to seven out of 35 patients. Overall, the titers of AMAs decline slightly during the first year post-OLT, but are equivalent to pre-OLT values by 6 months. Moreover, the antibody subclass/ isotype remained unchanged. These data suggest that the removal of a diseased PBC liver has little, if any, impact on the serological characteristics of PBC. Moreover, it provides information regarding the natural history of PBC, particularly on the long latency time for disease development.

[1]  M. Kaplan,et al.  Primary Biliary Cirrhosis , 1987, The New England journal of medicine.

[2]  H. Worman,et al.  Nuclear envelope protein autoantibodies in primary biliary cirrhosis. , 1997, Seminars in liver disease.

[3]  T. Therneau,et al.  Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: Relationship of levels of autoantibodies to disease progression , 1997, Hepatology.

[4]  David E. J. Jones,et al.  Natural history of early primary biliary cirrhosis , 1996, The Lancet.

[5]  K. Batts,et al.  Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis. , 1996, Hepatology.

[6]  E. Dickson,et al.  Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies , 1996, Hepatology.

[7]  Ross,et al.  Epitope mapping and reactivity of autoantibodies to the E2 component of 2‐oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2‐oxoglutarate dehydrogenase complex , 1996, Hepatology.

[8]  D. Chuang,et al.  Autoantibodies to BCOADC‐E2 in patients with primary biliary cirrhosis recognize a conformational epitope , 1995, Hepatology.

[9]  M. Manns,et al.  Is there recurrence of primary biliary cirrhosis after liver transplantation? A clinicopathologic study in long-term survivors. , 1994, Journal of hepatology.

[10]  H. Worman,et al.  Autoantibodies from patients with primary biliary cirrhosis recognize a restricted region within the cytoplasmic tail of nuclear pore membrane glycoprotein Gp210 , 1993, The Journal of experimental medicine.

[11]  S. Roberts,et al.  Study of procainamide hapten-specific antibodies in rabbits and humans. , 1993, International journal of immunopharmacology.

[12]  H. Krakauer,et al.  AN ANALYSIS OF LIVER TRANSPLANT EXPERIENCE FROM 37 TRANSPLANT CENTERS AS REPORTED TO MEDICARE , 1993, Transplantation.

[13]  B. Portmann,et al.  Recurrence of primary biliary cirrhosis after liver transplantation following FK506-based immunosuppression. , 1993, Journal of hepatology.

[14]  G. Gores,et al.  Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis , 1992, Hepatology.

[15]  R. Coppel,et al.  Molecular characterization of the mitochondrial autoantigens in primary biliary cirrhosis , 1991, Immunologic research.

[16]  J. Neuberger,et al.  Primary biliary cirrhosis: Histological evidence of disease recurrence after liver transplantation , 1993 .

[17]  R. Coppel,et al.  Site‐directed mutagenesis of lysine within the immunodominant autoepitope of PDC‐E2 , 1990, Hepatology.

[18]  E. Dickson,et al.  A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis. , 1990, The New England journal of medicine.

[19]  G. Minuk.  Cyclosporin A in nontransplant-related liver disease. , 1989, The American journal of gastroenterology.

[20]  J. Neuberger,et al.  Evidence for disease recurrence after liver transplantation for primary biliary cirrhosis , 1989 .

[21]  J. Neuberger,et al.  Evidence for disease recurrence after liver transplantation for primary biliary cirrhosis. Clinical and histologic follow-up studies. , 1989, Gastroenterology.

[22]  J. McGee,et al.  Kupffer cell number is normal, but their lysozyme content is reduced in alcoholic liver disease. , 1989, Journal of hepatology.

[23]  J. Neuberger,et al.  Does liver transplantation cure primary biliary cirrhosis? , 1989, Transplantation proceedings.

[24]  D. Smith,et al.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. , 1988, Gene.

[25]  B. Markus,et al.  Transplantation for primary biliary cirrhosis. , 1988, Gastroenterology.

[26]  Aftab J. Ahmed,et al.  The predominance of IgG3 and IgM isotype antimitochondrial autoantibodies against recombinant fused mitochondrial polypeptide in patients with primary biliary cirrhosis , 1988, Hepatology.

[27]  M. Manns,et al.  Subtypes of antimitochondrial antibodies in primary biliary cirrhosis before and after orthotopic liver transplantation , 1987, Hepatology.

[28]  D G Altman,et al.  Azathioprine and prognosis in primary biliary cirrhosis. , 1986, Gastroenterology.

[29]  A. Alberti,et al.  In vitro effect of lymphoblastoid alpha-interferon on subpopulations of effector cells mediating cytotoxicity for autologous hepatocytes in hepatitis B and non-A, non-B. , 1986, International journal of immunopharmacology.

[30]  J. Neuberger,et al.  Recurrence of primary biliary cirrhosis after liver transplantation. , 1982, The New England journal of medicine.